The Griffin Lab studies fundamental mechanisms of immune regulation in cancer and focus on the characterization and therapeutic targeting of chromatin silencing pathways in tumor immunity. We have developed a specific interest in the regulation of transposable elements and other highly repetitive regions of the genome, which have emerged as touchpoints for multiple immune regulatory processes in cancer. We aim to harness insights from these studies to develop better immune-based therapies for patients with cancer.